AzTrials
AzTrials

ResuscitationFRAGIREANCT03326635

Prevalence Study : Elderly Patients and Rehabilitation in ICU. Impact of Frailty.

An observational study of Resuscitation, run by Hospices Civils de Lyon at 37 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Study design. The study FRAGIREA is a multicentric prevalence study on the frequency of frailty among elderly patients and the quality of management. The voluntary ICUs will have to include all patients ≥ 70 years on a limited period (1 month) or until the number of 15 inclusions is reached. Read more about this study

Who is it for?
Ages 70 years and older
Conditions the study is for
Resuscitation
What is being tested?
Frailty in elderly (≥70 y) patients in ICU
How many people
527 participants
Where
37 sitesin 2 countries
Study dates
8 Apr 2018to 24 Jul 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Patients ≥ 70 year-old admitted to an ICU.

Who may be able to join

  • ≥ 70 year-old
  • Prevision of a length of stay > 24 hrs.
  • Patient or relative who received information about the study and did not oppose it

Who cannot join

  • Life expectancy < 24 hrs
  • Patients unable to communicate and no next of kin available.
  • adults, non-emancipated minors, persons unable to receive information,
  • persons placed under the safeguard of justice,
  • subject participating in another search including an exclusion period still in progress at pre-inclusion

Trial locations and contacts

37 sites in 2 countries.

37 sites in 2 countries

France36 sites
  • CH Aix en Provence

    Aix-en-Provence

  • CHU Angers

    Angers

  • CH Annecy

    Annecy

  • CH Annonay

    Annonay

  • CH Argentueil

    Argenteuil

  • CH Belfort

    Belfort

  • CH Béziers

    Béziers

  • CH Bourg en Bresse

    Bourg-en-Bresse

  • CH Bourgoin-Jallieu

    Bourgoin

  • CH Chalons sur Saône

    Chalon-sur-Saône

  • CH Chambéry

    Chambéry

  • CHU Clermont-Ferrand

    Clermont-Ferrand

  • CH Sud Francilien

    Évry

  • CHU Grenoble

    La Tronche

  • Hôpital Edouard Herriot, G Réa

    Lyon, 69003

  • Hôpital Edouard Herriot, N réa

    Lyon, 69003

  • Hôpital Edouard Herriot, P Réa

    Lyon, 69003

  • Hôpital de la Croix Rousse

    Lyon, 69005

  • AP-HM Hôpital Nord

    Marseille

  • AP-HM La Timone

    Marseille

  • CH Montauban

    Montauban

  • CH Montélimar

    Montélimar

  • CH Moulins

    Moulins

  • CHU Nantes

    Nantes

  • CHU Nice

    Nice

  • Centre Hospitalier Lyon Sud Réa Nord

    Pierre-Bénite, 69495

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, 69495

  • CHU Poitiers

    Poitiers

  • CHU de Rennes

    Rennes

  • CHU Rennes

    Rennes

  • CHU Rouen

    Rouen

  • CH Saint Denis

    Saint-Denis

  • CHU Hôpital Nord

    Saint-Etienne

  • CH Salons de Provence

    Salon-de-Provence

  • CH Valence

    Valence

  • CH Vichy

    Vichy

Other trials in France

Mayotte1 site
  • CH Mayotte

    Mayotte

About this study

Study design. The study FRAGIREA is a multicentric prevalence study on the frequency of frailty among elderly patients and the quality of management. The voluntary ICUs will have to include all patients ≥ 70 years on a limited period (1 month) or until the number of 15 inclusions is reached. The frailty is going to be evaluated by a frailty score adapted to the ICU, based on informations given by the patient's family.

It is a descriptive non-interventional study, aiming at the description of frequency of frailty and management of the patient in order to set-up a prospective future study on the potential role of early rehabilitation of ageing patients in ICUs.

Conditions
Resuscitation
Being tested
Frailty in elderly (≥70 y) patients in ICU
Keywords
Resuscitation, Frailty, ICU, Ageing, Rehabilitation, Elderly
Medical subject headings
Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Frailty in elderly (≥70 y) patients in ICUOther

    Determine the prevalence of frailty in elderly patients (≥ 70 year old) in a group of French ICUs. The frailty is measured by a score (Fried score) at the admission of the patient

Study groups in NCT03326635
Study groupRoleWhat they receive
frailty groupfrailty score ≤ 3
Receives: Other: Frailty in elderly (≥70 y) patients in ICU
non-frailty groupfrailty score >3
Receives: Other: Frailty in elderly (≥70 y) patients in ICU

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Frailty in elderly (≥70 years old) patients in intensive care unit (ICU)

    We assessed the 5 components of Fried's frailty index, resulting from cumulative decline across multiple physiological systems and contain five criteria (shrinking, weakness, slowness, low-level physical activity, and self-reported exhaustion). All five components were considered from the previously reported definition and adapted to the ICU environment. The patients were considered to be frail if they had three or more frailty components among the five criteria.

    Measured: One month or 15 patients ≥ 70 years old

Secondary outcomes (4)
  1. Organ failures

    During the patients' hospitalization in ICU, the following data were collected last day in ICU:

    the need for dialysis during ICU the duration of mechanical ventilation (number of days under mechanical ventilation) the duration of shock (number of days under catecholamines)

    Measured: About 8 days

  2. Nutritional support

    Nutritional intake during ICU stay, from the first day to the patient's exit, including route of administration (enteral, parenteral), last day in ICU we assessed:

    number of days under enteral nutrition number of days under enteral parenteral nutrition calculation of the average calorie / day

    Measured: About 8 days

  3. Rehabilitation

    Last day in ICU, we record the highest level of mobilization achieved during the ICU period, the following ordinal scale was used: 1) no mobilization, 2) turning in bed, 3) sitting in bed with the head of bed elevated, 4) sitting on the edge of the bed with feet on floor, 5) sitting out of bed in a chair, 6) standing out of bed, 7) marching in place, 8) walking, 9) using cycloergometer and 9) using electrical muscle stimulation.

    Measured: About 8 days

  4. Mortality

    ICU mortality and Hospital mortality Decision of therapeutics limitation. Length of stay (ICU and hospital stay).

    Measured: 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2017
  2. Study start8 Apr 2018
  3. Primary completion25 Jan 2019
  4. Study completion24 Jul 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
527 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03326635
Sponsor's protocol ID
69HCL17_0017
Acronym
FRAGIREA
Status last verified
Aug 2019
First submitted
17 Oct 2017
Last updated
14 Aug 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Resuscitation, run by Hospices Civils de Lyon at 37 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 37 sites in France, Mayotte. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Frailty in elderly (≥70 years old) patients in intensive care unit (ICU) (time frame: One month or 15 patients ≥ 70 years old). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in